SPHERA FUNDS MANAGEMENT LTD. - Q2 2018 holdings

$725 Million is the total value of SPHERA FUNDS MANAGEMENT LTD.'s 110 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 69.2% .

 Value Shares↓ Weighting
NewSPDR SERIES TRUSTput$71,393,000750,000
+100.0%
9.84%
MRK BuyMERCK & CO INC$41,276,000
+30.6%
680,000
+17.2%
5.69%
+18.6%
MYL BuyMYLAN N V$30,864,000
+30.6%
854,000
+48.8%
4.26%
+18.6%
GSK BuyGLAXOSMITHKLINE PLCsponsored adr$30,837,000
+57.9%
765,000
+53.0%
4.25%
+43.3%
GILD NewGILEAD SCIENCES INC$25,148,000355,000
+100.0%
3.47%
NewISHARES TRput$24,566,000150,000
+100.0%
3.39%
SHPG SellSHIRE PLCsponsored adr$21,353,000
-27.3%
126,500
-35.6%
2.94%
-33.9%
ALXN BuyALEXION PHARMACEUTICALS INC$19,932,000
+118.1%
160,544
+95.8%
2.75%
+98.0%
ALNY NewALNYLAM PHARMACEUTICALS INC$19,228,000195,232
+100.0%
2.65%
SRPT SellSAREPTA THERAPEUTICS INC$19,179,000
+4.0%
145,096
-41.7%
2.64%
-5.6%
FOLD SellAMICUS THERAPEUTICS INC$18,573,000
-33.1%
1,189,056
-35.6%
2.56%
-39.2%
AMGN NewAMGEN INC$18,459,000100,000
+100.0%
2.54%
BIIB SellBIOGEN INC$14,512,000
-18.5%
50,000
-23.1%
2.00%
-25.9%
PFE SellPFIZER INC$14,149,000
-32.4%
390,000
-33.9%
1.95%
-38.6%
CLSD BuyCLEARSIDE BIOMEDICAL INC$11,425,000
+3.4%
1,068,720
+3.8%
1.58%
-6.1%
BLUE NewBLUEBIRD BIO INC$11,376,00072,483
+100.0%
1.57%
AGN  ALLERGAN PLC$10,003,000
-0.9%
60,0000.0%1.38%
-10.0%
CLLS BuyCELLECTIS S Asponsored ads$9,955,000
-6.9%
351,874
+3.7%
1.37%
-15.5%
RTRX BuyRETROPHIN INC$9,625,000
+95.7%
353,072
+60.5%
1.33%
+77.6%
ARQL SellARQULE INC$8,282,000
+27.0%
1,497,683
-33.9%
1.14%
+15.4%
INNT  INNOVATE BIOPHARMACEUTICLS I$7,844,000
-36.0%
980,5020.0%1.08%
-41.9%
VKTX SellVIKING THERAPEUTICS INC$7,425,000
+6.7%
782,424
-50.9%
1.02%
-3.1%
MSFT BuyMICROSOFT CORP$7,340,000
+20.3%
74,435
+11.3%
1.01%
+9.3%
IMMU SellIMMUNOMEDICS INC$7,259,000
+3.5%
306,655
-36.1%
1.00%
-6.0%
MLNX SellMELLANOX TECHNOLOGIES LTD$7,246,000
-0.8%
85,954
-14.3%
1.00%
-9.9%
NERV BuyMINERVA NEUROSCIENCES INC$6,766,000
+39.7%
820,120
+5.8%
0.93%
+26.9%
ALDX SellALDEYRA THERAPEUTICS INC$6,733,000
-11.0%
846,935
-16.1%
0.93%
-19.2%
KURA BuyKURA ONCOLOGY INC$6,406,000
+3.5%
351,953
+6.7%
0.88%
-6.0%
SODA NewSODASTREAM INTERNATIONAL LTD$6,292,00073,762
+100.0%
0.87%
MLNT BuyMELINTA THERAPEUTICS INC$6,252,000
+246.4%
984,492
+303.7%
0.86%
+214.6%
NICE SellNICE LTDsponsored adr$6,231,000
-2.1%
60,043
-11.4%
0.86%
-11.1%
KDMN BuyKADMON HLDGS INC$6,196,000
-2.2%
1,552,846
+4.2%
0.85%
-11.2%
QURE BuyUNIQURE NV$5,764,000
+92.2%
152,490
+19.5%
0.80%
+74.7%
ARRY SellARRAY BIOPHARMA INC$5,702,000
-13.7%
339,804
-16.1%
0.79%
-21.7%
ADMS SellADAMAS PHARMACEUTICALS INC$5,518,000
-31.2%
213,625
-36.3%
0.76%
-37.5%
BHVN BuyBIOHAVEN PHARMACTL HLDG CO L$5,430,000
+60.8%
137,388
+4.8%
0.75%
+46.0%
AGLE NewAEGLEA BIOTHERAPEUTICS INC$5,386,000509,118
+100.0%
0.74%
V  VISA INC$5,351,000
+10.7%
40,4010.0%0.74%
+0.5%
ASND SellASCENDIS PHARMA A Ssponsored adr$5,192,000
-16.8%
78,048
-18.3%
0.72%
-24.5%
ZFGN NewZAFGEN INC$4,910,000480,000
+100.0%
0.68%
RETA SellREATA PHARMACEUTICALS INCcl a$4,757,000
+3.1%
136,044
-39.5%
0.66%
-6.4%
AUTL NewAUTOLUS THERAPEUTICS PLCspon ads$4,716,000176,045
+100.0%
0.65%
SESN NewSESEN BIO INC$4,635,0002,377,068
+100.0%
0.64%
WAB NewWABTEC CORP$4,590,00046,564
+100.0%
0.63%
ARPO NewAERPIO PHARMACEUTICALS INC$4,580,0001,103,554
+100.0%
0.63%
LPTX BuyLEAP THERAPEUTICS INC$4,492,000
+26.7%
499,137
+16.9%
0.62%
+15.1%
MA BuyMASTERCARD INCORPORATEDcl a$4,473,000
+54.5%
22,760
+37.7%
0.62%
+40.2%
SRRK NewSCHOLAR ROCK HLDG CORP$4,430,000283,997
+100.0%
0.61%
CTIC BuyCTI BIOPHARMA CORP$4,355,000
+34.0%
874,407
+4.9%
0.60%
+21.5%
CSCO NewCISCO SYS INC$4,303,000100,000
+100.0%
0.59%
PIRS BuyPIERIS PHARMACEUTICALS INC$4,272,000
-21.7%
842,632
+5.3%
0.59%
-28.9%
EPZM NewEPIZYME INC$4,162,000307,154
+100.0%
0.57%
SBBP NewSTRONGBRIDGE BIOPHARMA PLC$4,044,000673,996
+100.0%
0.56%
XENE NewXENON PHARMACEUTICALS INC$4,039,000439,034
+100.0%
0.56%
KZR NewKEZAR LIFE SCIENCES INC$3,943,000227,900
+100.0%
0.54%
GLYC BuyGLYCOMIMETICS INC$3,870,000
+58.9%
239,933
+60.0%
0.53%
+44.3%
FB BuyFACEBOOK INCcl a$3,712,000
+281.1%
19,100
+213.3%
0.51%
+245.9%
GOOGL SellALPHABET INCcap stk cl a$3,691,000
-25.7%
3,269
-31.8%
0.51%
-32.6%
CRVS BuyCORVUS PHARMACEUTICALS INC$3,689,000
-0.5%
335,987
+4.5%
0.51%
-9.6%
OBSV SellOBSEVA SA$3,689,000
-63.3%
243,669
-67.3%
0.51%
-66.6%
DCPH BuyDECIPHERA PHARMACEUTICALS IN$3,661,000
+347.0%
93,031
+127.8%
0.50%
+307.3%
FLEX SellFLEX LTDord$3,666,000
-27.1%
259,824
-15.6%
0.50%
-33.8%
PRQR SellPROQR THRAPEUTICS N V$3,604,000
+78.0%
493,749
-25.0%
0.50%
+61.9%
ABEO SellABEONA THERAPEUTICS INC$3,571,000
-15.6%
223,172
-24.3%
0.49%
-23.5%
EVOK BuyEVOKE PHARMA INC$3,527,000
+330.6%
1,410,946
+258.2%
0.49%
+291.9%
ALNA SellALLENA PHARMACEUTICALS INC$3,484,000
-22.9%
267,349
-34.8%
0.48%
-30.0%
CSTE BuyCAESARSTONE LTD$3,485,000
+1352.1%
230,816
+1792.7%
0.48%
+1233.3%
VRTX NewVERTEX PHARMACEUTICALS INC$3,399,00020,000
+100.0%
0.47%
SRRA BuySIERRA ONCOLOGY INC$3,184,000
+53.8%
1,075,806
+7.6%
0.44%
+39.8%
ORLY  O REILLY AUTOMOTIVE INC NEW$2,967,000
+10.6%
10,8440.0%0.41%
+0.5%
WIX NewWIX COM LTD$2,963,00029,542
+100.0%
0.41%
FIXX BuyHOMOLOGY MEDICINES INC$2,893,000
+16.3%
141,836
+6.6%
0.40%
+5.6%
ELOX NewELOXX PHARMACEUTICALS INC$2,859,000167,474
+100.0%
0.39%
FSCT NewFORESCOUT TECHNOLOGIES INC$2,617,00076,400
+100.0%
0.36%
LRCX BuyLAM RESEARCH CORP$2,523,000
-7.0%
14,597
+9.3%
0.35%
-15.5%
VRCA NewVERRICA PHARMACEUTICALS INC$2,482,000125,800
+100.0%
0.34%
APTX NewAPTINYX INC$2,477,000102,474
+100.0%
0.34%
APLS NewAPELLIS PHARMACEUTICALS INC$2,438,000110,803
+100.0%
0.34%
MRVL NewMARVELL TECHNOLOGY GROUP LTDord$2,355,000109,842
+100.0%
0.32%
SEDG BuySOLAREDGE TECHNOLOGIES INC$2,342,000
+159.1%
48,948
+184.7%
0.32%
+135.8%
KRNT NewKORNIT DIGITAL LTD$2,329,000130,831
+100.0%
0.32%
NEOS BuyNEOS THERAPEUTICS INC$2,201,000
-17.3%
352,142
+9.8%
0.30%
-25.0%
CTMX SellCYTOMX THERAPEUTICS INC$1,901,000
-62.9%
83,142
-53.8%
0.26%
-66.3%
VTGN BuyVISTAGEN THERAPEUTICS INC$1,879,000
+62.4%
1,371,892
+10.0%
0.26%
+47.2%
TBIO NewTRANSLATE BIO INC$1,645,000130,000
+100.0%
0.23%
GILT BuyGILAT SATELLITE NETWORKS LTD$1,501,000
+52.4%
163,367
+46.3%
0.21%
+38.0%
PTLA NewPORTOLA PHARMACEUTICALS INC$1,385,000120,000
+100.0%
0.19%
DK SellDELEK US HLDGS INC NEW$1,231,000
-75.3%
24,533
-79.9%
0.17%
-77.5%
ZYME NewZYMEWORKS INC$1,091,00073,800
+100.0%
0.15%
RDCM SellRADCOM LTD$1,042,000
-13.7%
52,760
-19.8%
0.14%
-21.3%
 TEVA PHARMACEUTICAL FIN LLCdbcv 0.250% 2/0$970,000
+38.0%
2,1350.0%0.13%
+25.2%
AAP  ADVANCE AUTO PARTS INC$724,000
+14.4%
5,3360.0%0.10%
+4.2%
MRTX NewMIRATI THERAPEUTICS INC$707,00014,335
+100.0%
0.10%
AQXP BuyAQUINOX PHARMACEUTICALS INC$683,000
-35.8%
257,613
+241.1%
0.09%
-42.0%
RCKT SellROCKET PHARMACEUTICALS INC$677,000
-88.1%
34,475
-88.6%
0.09%
-89.2%
TCDA NewTRICIDA INC$610,00020,410
+100.0%
0.08%
BMRN NewBIOMARIN PHARMACEUTICAL INC$589,0006,250
+100.0%
0.08%
SERV  SERVICEMASTER GLOBAL HLDGS I$565,000
+17.0%
9,5000.0%0.08%
+6.8%
UNH  UNITEDHEALTH GROUP INC$491,000
+14.7%
2,0000.0%0.07%
+4.6%
AUDC NewAUDIOCODES LTDord$461,00059,226
+100.0%
0.06%
RDWR SellRADWARE LTDord$443,000
+13.9%
17,527
-3.9%
0.06%
+3.4%
CHTR SellCHARTER COMMUNICATIONS INC Ncl a$416,000
-59.8%
1,419
-57.4%
0.06%
-63.7%
SITE  SITEONE LANDSCAPE SUPPLY INC$252,000
+9.1%
3,0000.0%0.04%0.0%
MHK  MOHAWK INDS INC$236,000
-7.5%
1,1000.0%0.03%
-15.4%
CISN NewCISION LTD$224,00015,000
+100.0%
0.03%
SNA  SNAP ON INC$220,000
+8.9%
1,3660.0%0.03%
-3.2%
EIDX NewEIDOS THERAPEUTICS INC$220,00010,828
+100.0%
0.03%
ULTI  ULTIMATE SOFTWARE GROUP INC$206,000
+5.6%
8000.0%0.03%
-6.7%
KMPH NewKEMPHARM INC$147,00022,622
+100.0%
0.02%
LPSN ExitLIVEPERSON INC$0-136
-100.0%
0.00%
ATHX ExitATHERSYS INC$0-773
-100.0%
0.00%
VSTO ExitVISTA OUTDOOR INC$0-6,000
-100.0%
-0.02%
XRAY ExitDENTSPLY SIRONA INC$0-2,500
-100.0%
-0.02%
GLIBA ExitGCI LIBERTY INC$0-3,000
-100.0%
-0.02%
SEE ExitSEALED AIR CORP NEW$0-4,500
-100.0%
-0.03%
CMCSA ExitCOMCAST CORP NEWcl a$0-10,000
-100.0%
-0.05%
WSO ExitWATSCO INC$0-2,100
-100.0%
-0.06%
VTVT ExitVTV THERAPEUTICS INCcl a$0-281,679
-100.0%
-0.17%
PRGO ExitPERRIGO CO PLC$0-19,221
-100.0%
-0.24%
FGEN ExitFIBROGEN INC$0-39,779
-100.0%
-0.28%
EXPE ExitEXPEDIA GROUP INC$0-18,900
-100.0%
-0.32%
VBIV ExitVBI VACCINES INC$0-666,284
-100.0%
-0.35%
ERYP ExitERYTECH PHARMAsponsored adr$0-120,000
-100.0%
-0.38%
ASNS ExitARSANIS INC$0-114,972
-100.0%
-0.40%
BOLD ExitAUDENTES THERAPEUTICS INC$0-95,000
-100.0%
-0.43%
CHRS ExitCOHERUS BIOSCIENCES INC$0-270,000
-100.0%
-0.45%
RGNX ExitREGENXBIO INC$0-100,000
-100.0%
-0.45%
CMTA ExitCLEMENTIA PHARMACEUTICALS IN$0-200,000
-100.0%
-0.46%
GEMP ExitGEMPHIRE THERAPEUTICS INC$0-481,046
-100.0%
-0.48%
ENDP ExitENDO INTL PLC$0-550,000
-100.0%
-0.50%
NTLA ExitINTELLIA THERAPEUTICS INC$0-160,000
-100.0%
-0.51%
MGNX ExitMACROGENICS INC$0-135,000
-100.0%
-0.52%
REPH ExitRECRO PHARMA INC$0-364,197
-100.0%
-0.61%
PBYI ExitPUMA BIOTECHNOLOGY INC$0-60,000
-100.0%
-0.62%
SNDX ExitSYNDAX PHARMACEUTICALS INC$0-298,472
-100.0%
-0.64%
EIGR ExitEIGER BIOPHARMACEUTICALS INC$0-475,000
-100.0%
-0.71%
TSRO ExitTESARO INC$0-106,175
-100.0%
-0.92%
MNOV ExitMEDICINOVA INC$0-630,838
-100.0%
-0.98%
PTLA ExitPORTOLA PHARMACEUTICALS INCcall$0-200,000
-100.0%
-0.99%
LJPC ExitLA JOLLA PHARMACEUTICAL CO$0-260,000
-100.0%
-1.18%
CLVS ExitCLOVIS ONCOLOGY INC$0-168,000
-100.0%
-1.35%
QQQ ExitPOWERSHARES QQQ TRUSTput$0-80,000
-100.0%
-1.94%
REGN ExitREGENERON PHARMACEUTICALS$0-41,500
-100.0%
-2.17%
CELG ExitCELGENE CORP$0-319,000
-100.0%
-4.32%
XBI ExitSPDR SERIES TRUSTput$0-750,000
-100.0%
-9.99%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2018-08-13
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
TEVA PHARMACEUTICAL-SP ADR36Q3 20238.4%
MERCK & CO INC NEW35Q3 20238.4%
NICE Systems Ltd27Q3 20234.4%
BIOGEN INC26Q3 20236.7%
AMICUS THERAPEUTICS INC26Q2 20224.3%
PFIZER INC25Q3 20239.2%
SAREPTA THERAPEUTICS INC25Q3 20233.2%
JOHNSON & JOHNSON24Q3 20238.0%
UNIQURE NV23Q3 20231.2%
SYNDAX PHARMACEUTICALS INC22Q3 20233.9%

View SPHERA FUNDS MANAGEMENT LTD.'s complete holdings history.

Latest significant ownerships (13-D/G)

View SPHERA FUNDS MANAGEMENT LTD.'s complete significant-ownership history.

Latest filings
TypeFiled
13F-HR/A2024-02-15
13F-HR2024-02-14
SC 13G2024-02-08
SC 13G/A2024-02-05
SC 13G/A2024-02-05
SC 13G/A2024-02-05
SC 13G/A2024-02-05
13F-HR2023-11-14
SC 13G2023-10-10
SC 13G2023-08-30

View SPHERA FUNDS MANAGEMENT LTD.'s complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (725360000.0 != 725363000.0)

Export SPHERA FUNDS MANAGEMENT LTD.'s holdings